SJS Investment Consulting »

Heron Therapeutics shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1k 400 2.77

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Hormel Foods Corporation (HRL)
Eli Lilly & Co. (LLY)
Dimensional Etf Trust Short Duration F (DFSD)
Apple (AAPL)
Dimensional Etf Trust World Ex Us Core (DFAX)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Core Fixed Incom (DFCF)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Dimensional Etf Trust Global Real Est (DFGR)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Emerging Mkts Co (DFEM)

View all positions for SJS Investment Consulting

Top funds holding Heron Therapeutics

Vanguard Group
Franklin Resources
Clearline Capital
OrbiMed Advisors
Tejara Capital
Palisade Capital Management
JW Asset Management
Orchard Capital Managment
Monaco Asset Management SAM
Tang Capital Management
Congress Park Capital
D. E. Shaw & Co
Millennium Management
New York State Common Retirement Fund
Charles Schwab Investment Management

View all funds holding Heron Therapeutics